LuyovaLab joins CMS health tech ecosystem and Blue Button 2.0

LuyovaLab has been approved as a Friend of the CMS Health Tech Ecosystem and has joined workgroups focused on price transparency, diagnostic imaging and patient-facing apps. The company is also building a Blue Button 2.0 connection so Medicare beneficiaries can bring claims history into their LuyovaLab records alongside test results.

Why it matters: - LuyovaLab’s CMS approval puts the diagnostic platform inside a federal effort to make health data easier for people to access and use. - The Blue Button 2.0 work could let Medicare beneficiaries combine claims history with lab results in one place. - The company’s participation in CMS workgroups gives it a role in shaping tools tied to transparency, imaging and consumer-facing apps.

What happened: - LuyovaLab was approved by the Centers for Medicare & Medicaid Services as a Friend of the CMS Health Tech Ecosystem. - The approval was announced Nov. 10, 2026. - LuyovaLab joined three CMS Ecosystem workgroups: Price Transparency, Ditch the Disk for diagnostic imaging and Patient Facing Apps. - LuyovaLab registered with the CMS Blue Button 2.0 developer program and began building a connection to the Medicare data stream.

The details: - The Health Tech Ecosystem launched at the White House in July 2025. - CMS designed the ecosystem to connect technology companies, providers and health networks around secure access to personal health information. - LuyovaLab plans to let users who choose to do so bring their own Medicare claims history into their LuyovaLab record next to their test results. - LuyovaLab organizes testing across 12 health pathways, ranging from foundational testing to deeper analysis. - The platform lets people track lab results over time in a plain-language dashboard. - LuyovaLab says the platform is HIPAA compliant. - The company says Business Associate Agreements are in place with every partner that handles health information. - Every order is reviewed by a licensed practitioner in the person’s state. - A 90-second platform video is available on YouTube. - Early access is open at LuyovaLab.com.

Between the lines: - LuyovaLab is positioning itself as more than a testing provider; the company is tying its product to federal interoperability efforts. - The CMS relationship may help the platform appeal to consumers and partners that want lab data, claims data and imaging workflows connected in one place. - The emphasis on plain-language results and privacy suggests LuyovaLab is targeting users who want easier-to-read health data without giving up oversight.

What's next: - LuyovaLab will continue building its Blue Button 2.0 integration. - The company is likely to keep participating in CMS workgroups as the ecosystem develops. - Early access remains open as LuyovaLab expands its platform and federal connectivity efforts.

The bottom line: - LuyovaLab is trying to anchor its diagnostic platform inside the broader push for connected, consumer-controlled health data.